| Quarter (USD) | Sep 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 204.00 mm | 204.00 mm | 204.00 mm | 204.00 mm | 204.00 mm | |
| Cash burn (monthly) | (no burn) | 3.08 mm | 35.00 mm | 29.92 mm | 17.33 mm | |
| Cash used (since last report) | n/a | 8.63 mm | 97.98 mm | 83.75 mm | 48.52 mm | |
| Cash remaining | n/a | 195.37 mm | 106.02 mm | 120.25 mm | 155.48 mm | |
| Runway (months of cash) | n/a | 63.4 | 3.0 | 4.0 | 9.0 | |
| 13F holders | Current |
|---|---|
| Total holders | 198 |
| Opened positions | 65 |
| Closed positions | 21 |
| Increased positions | 56 |
| Reduced positions | 53 |
| 13F shares | Current |
|---|---|
| Total value | 763.91 bn |
| Total shares | 86.01 mm |
| Total puts | 151.10 k |
| Total calls | 172.80 k |
| Total put/call ratio | 0.9 |
| Largest owners | Shares | Value |
|---|---|---|
| GILD Gilead Sciences | 25.59 mm | $514.30 mm |
| BLK BlackRock | 9.76 mm | $148.69 bn |
| Vanguard | 5.26 mm | $80.07 bn |
| Woodline Partners | 4.25 mm | $64.65 bn |
| FMR | 4.18 mm | $63.67 bn |
| STT State Street | 3.06 mm | $46.53 bn |
| GV 2016 | 2.56 mm | $0.00 |
| Biotechnology Value Fund L P | 2.30 mm | $0.00 |
| Foresite Capital Fund III | 2.03 mm | $21.85 mm |
| Point72 Asset Management | 1.83 mm | $27.93 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 Dec 24 | Alexander Azoy | Common Stock | Sale back to company | Dispose D | No | Yes | 15.17 | 3,007 | 45.62 k | 13,094 |
| 15 Dec 24 | Goeltz II Robert C. | Common Stock | Payment of exercise | Dispose F | No | No | 16.08 | 10,099 | 162.39 k | 63,732 |
| 15 Dec 24 | Alexander Azoy | Common Stock | Payment of exercise | Dispose F | No | No | 16.08 | 2,969 | 47.74 k | 16,101 |
| 15 Dec 24 | Jaen Juan C. | Common Stock | Payment of exercise | Dispose F | No | No | 16.08 | 17,286 | 277.96 k | 317,220 |
| 15 Dec 24 | Jarrett Jennifer | Common Stock | Payment of exercise | Dispose F | No | No | 16.08 | 27,501 | 442.22 k | 163,369 |
